EDAP TMS S.A. (EDAP)

[BooDog]

EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota




EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota

LYON, France, February 27, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at the University of Minnesota, Minneapolis, using the Company's FDA-cleared Ablatherm Robotic HIFU. The Department of Urology at the University of Minnesota Medical School is recognized as one of the leading urology departments in the United States.

Dr. Badrinath Konety, Chair, Department of Urology University of Minnesota Director, Institute for Prostate and Urologic Cancers, commented: "We are delighted to be the first center in the upper Midwest to offer Ablatherm Robotic HIFU. We find it to be an excellent low morbidity treatment option for appropriately selected patients with prostate cancer."

Marc Oczachowski, EDAP TMS Chief Executive Officer, added: "We are very pleased to add the prestigious University of Minnesota to our list of HIFU centers in the U.S. and to work in close collaboration with Dr. B. Konety in supporting HIFU adoption among the urology community. By partnering with HIFU Solution, we increase the availability of HIFU treatments for U.S. patients by offering mobile HIFU access to hospitals and clinics. We look forward to continuing to extend our HIFU education programs throughout the country to as many American urologists as possible."

Dr. P. Narayan MD, HIFU Solution Medical Director, commented: "It is with great pleasure that HIFU Solution, in conjunction with Urologists and Surgical centers, was able to offer mobile HIFU to patients of the state of Minnesota, utilizing the innovative Ablatherm treatment device from EDAP. We will be offering this HIFU service to many doctors in the urology community around the country."

http://investor.edap-tms.com/releasedetail.cfm?ReleaseID=1014588


Expanding and infiltrating further into the market. That's a good thing.